Synthesis and anti-human immunodeficiency virus type 1 integrase activity of hydroxybenzoic and hydroxycinnamic acid flavon-3-yl esters

Antiviral Chemistry and Chemotherapy

Volumn 9, Issue 6, 1998, Pages 497-509

  Desideri, N ^a   Sestili, I ^a   Stein, M L ^a   Tramontano, E ^b   Corrias, S ^b   La Colla, P ^b  

^a SAPIENZA UNIVERSITY OF ROME   (Italy)

^b UNIVERSITY OF CAGLIARI   (Italy)

Author keywords

Caffeic acid esters; Flavonoids; Gallic acid esters; HIV 1; Integrase inhibitors

Indexed keywords

4 HYDROXYBENZOIC ACID ESTER; ANTI HUMAN IMMUNODEFICIENCY VIRUS AGENT; CAFFEIC ACID DERIVATIVE; COUMARIC ACID; DNA TOPOISOMERASE; GALLIC ACID DERIVATIVE; INTEGRASE; INTEGRASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; UNINDEXED DRUG;

ARTICLE; CONTROLLED STUDY; DRUG POTENCY; DRUG SYNTHESIS; DRUG TARGETING; ENZYME ASSAY; ENZYME INHIBITION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; PRIORITY JOURNAL; VIRUS REPLICATION;

EID: 0031764223     PISSN: 09563202     EISSN: None     Source Type: Journal    
DOI: 10.1177/095632029800900606     Document Type: Article

References (50)

1. Allen CFH & Byers JR Jr (1949) Synthesis of coniferyl alcohol and coniferyl benzoate. Journal of the American Chemistry Society 71:2683-2684.
2. Andrake MD & Skalka AM. (1996) Retroviral integrase, putting the pieces together. Journal of Biological Chemistry 271:19633-19636.
3. Austin CA, Patel S, Ono K, Nakane H & Fisher LM (1992) Site-specific DNA cleavage by mammalian DNA topoisomerase II induced by novel flavone and catechin derivatives. Biochemical Journal 282:883-889.
4. Burali C, Desideri N, Stein ML, Conti C & Orsi N (1987) Synthesis and anti-rhinovirus activity of halogen substituted isoflavenes and isoflavans. European Journal of Medicinal Chemistry 22:119-123.
5. Burke TR, Fesen MR, Mazumder A, Wang Y, Carothers AM, Grunberger D, Driscoll J, Khon KW & Pommier Y (1995) Hydroxylated aromatic inhibitors of HIV-1 integrase. Journal of Medicinal Chemistry 38:4171-4178.
6. Cheng PL, Fournari P & Tirouflet J (1963) Reserches en série hétérocyclique. VII. Syntèse de chromannones et o-hydroxychalcones substituées sur le differents cycles. Bulletin de la Societe Chimique de France 2248-2251.
7. Conti C, Orsi N & Stein ML (1988) Effect of isoflavans and isoflavenes on rhinovirus 1B and its replication in HeLa cells. Antiviral Research 10:117-127.
8. Conti C, Desideri N, Orsi N, Sestili I & Stein ML (1990a) Synthesis and anti-rhinovirus activity of cyano and amidino substituted flavanoids European Journal of Medicinal Chemistry 25:725-730.
9. Conti C, Genovese D, Santoro R, Stein ML, Orsi N & Fiore L (1990b) Activities and mechanisms of action of halogen-substituted flavanoids against poliovirus type 2 infection in vitro. Antimicrobial Agents and Chemotherapy 34:460-466.
10. Conti C, Tomao P, Genovese D, Desideri N, Stein ML & Orsi N (1992) Mechanism of action of antirhinovirus flavanoid 4′,6-dicyanoflavan. Antimicrobial Agents and Chemotherapy 36:95-99.
11. De Clercq E (1994) HIV resistance to reverse transcriptase inhibitors. Biochemical Pharmacology 47:155-169.
12. De Clercq E (1995) Toward improved anti-HIV chemotherapy: therapeutic strategies for intervention with HIV infections Journal of Medicinal Chemistry 38:2491-2517.
13. Deulofeu V & Schopflocher N (1953) The flavonic glucosides of Ombu (Phytolacca dioica). III. The synthesis of ombuin and of other flavonic derivatives of isovanillic series. Gazzetta Chimica Italiana 83:449-453.
14. Desideri N, Sestili I, Stein ML, Conti C, Tomao P & Orsi N (1990) Synthesis and anti-rhinovirus 1B activity of oxazolinylflavans. Antiviral Chemistry and Chemotherapy 1:307-312.
15. Desideri N, Conti C, Sestili I, Tomao P, Stein ML & Orsi N (1992) Synthesis and evaluation of anti-rhinovirus 1B activity of oxazolinyl-isoflavans and -3(2 H)-isoflavenes. Antiviral Chemistry and Chemotherapy 3:195-202.
16. Desideri N, Conti C, Sestili I, Tomao P, Stein ML & Orsi N (1995) In vitro evaluation of the anti-picornavirus activities of new synthetic flavonoids. Antiviral Chemistry and Chemotherapy 6:298-306.
17. Desideri N, Olivieri S, Stein ML, Sgro R, Orsi N & Conti C (1997) Synthesis and anti-picornavirus activity of homoisoflavonoids. Antiviral Chemistry and Chemotherapy 8:545-555.
18. Ferriola PC, Cody V & Middetlon E (1989) Protein kinase C inhibition by plant flavanoids. Kinetic mechanisms and structure-activity relationships. Biochemical Pharmacology 38:1617-1622.
19. Fesen MR, Pommier Y, Leteurtre F, Hiroguchi S, Yung J & Khon KW (1994) Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds. Biochemical Pharmacology 48:595-608.
20. Freudenberg K & Hüber HH (1952) Oxyzimtalkohole und ihre Dehydrierungs-polymerisate. Chemische Berichte 85:1181-1191.
21. Freudenberg K & Heel W (1953) Dioxy-und Trioxy-zimtalkohol. Chemische Berichte 86:190-196.
22. Genovese D, Conti C, Tomao P, Desideri N, Stein ML, Catone S & Fiore L (1995) Effect of chloro, cyano, and amidino-substituted flavanoids on enterovirus infection in vitro. Antiviral Research 27:123-136.
23. Havsteen B (1983) Flavonoids, a class of natural products of high pharmacological potency. Biochemical Pharmacology 32:1141-1148.
24. Hazuda D, Felock P, Hastings JC, Pramanik B & Wolfe AL (1997) Differential divalent cation requirements uncouple the assembly and catalytic reactions of human immunodeficiency virus type 1 integrase. Journal of Virology 71:7005-7011.
25. Johnson VA (1996) Combination therapy for HIV-1 infection overview: preclinical and clinical analysis of antiretroviral combinations. Antiviral Research 29:35-39.
26. Kallay F & Janzs G (1974) Flavonoid chemistry research. Kemiai Kazlemenyek 42:213-223.
27. Kulkosky J & Skalta AM (1994) Molecular mechanism of retroviral integration. Pharmacology and Therapeutics 61:185-203.
28. La Femina RL, Graham PL, Le Grow K, Hastings JC, Wolfe A, Young SD, Emini EA & Hazuda DJ (1995) Inhibition of human immunodeficiency virus integrase by bis-catechols. Antimicrobial Agents and Chemotherapy 39:320-324.
29. Lee KH, Imakura Y, Beers SA, Thurston LS, Dai HJ & Chen CH (1989) Antitumor agent 107. New cytotoxic 4-alkylammo analogues of 4′-demethyl-epipodophyllotoxin as inhibitors of human DNA topoisomerase II. Journal of Natural Products 52:606-613.
30. Levitzki A & Gazit A (1995) Tyrosine kinase inhibition: an approach to drug development. Science 267:1782-1788.
31. Mazumder A, Raghavan K, Weistein J, Kohn KW & Pommier Y (1995a) Inhibition of human immunodeficiency virus type-1 integrase by curcumin. Biochemical Pharmacology 49:1165-1170.
32. Mazumder A, Gazit A, Levitzki A, Nicklaus M, Yung J, Kohlhagen G & Pommier Y (1995b) Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase. Biochemistry 34:15111-15122.
33. Mekouar K, Mouscadet JF, Desmaele D, Subra F, Leh H, Savouré D, Auclair C & d'Angelo J (1998) Styrylquinoline derivatives: a new class of potent HIV-1 integrase inhibitors that block HIV-1 replication in CEM cells. Journal of Medicinal Chemistry 41:2846-2857.
34. Moore PS & Pizza C (1992) Observations on the inhibition of HIV-1 reverse transcriptase by catechins. Biochemical Journal 288:717-719.
35. Nakane H & Ono K (1990) Differential inhibitory effects of some catechin derivatives on the activities of human immunodeficiency virus reverse transcriptase and cellular deoxyribonucleic and ribonucleic acid polymerases. Biochemistry 29:2841-2845.
36. Neamati N, Mazumder A, Zhao H, Sunder S, Burke TR, Schultz RJ & Pommier Y (1997a) Diarylsulfones, a novel class of human immunodeficiency virus type 1 integrase inhibitors. Antimicrobial Agents and Chemotherapy 41:385-393.
37. Neamati N, Mazumder H, Sunder S, Owen JM, Schultz RJ & Pommier Y (1997b) 2-Mercaptobenzenesulfonamides as novel inhibitors of human immunodeficiency virus type 1 integrase and replication. Antimicrobial Agents and Chemotherapy 41:485-495.
38. Nishizawa M, Yamagishi T, Dutschman GE, Parker WB, Bodner AJ, Kilkuskie RE, Cheng YC & Lee KH (1989) Anti-AIDS agents, 1. Isolation and characterization of four new tetragalloylquinic acids as a new class of HIV reverse transcriptase inhibitors from tannic acid. Journal of Natural Products 52:762-768.
39. Ono K, Nakane H, Fukushima M, Chermann JC & Barré Sinoussi F (1990) Differential inhibitory effects of various flavonoids on the activities of reverse transcriptase and cellular DNA and RNA polymerases. European Journal of Biochemistry 190:469-476.
40. Pauwels R, Balzarini J, Baba M, Snoeck R, Schols D, Herdewijn P Desmyster J & DeClercq E (1988) Rapid and automated tetrazolium-based assay for the detection of anti-HIV compounds. Journal of Virological Methods 20:309-321.
41. Pommier Y, Pilon AA, Bajaj K, Mazumder A & Neamati N (1997) HIV-1 integrase as a target for antiviral drugs. Antiviral Chemistry and Chemotherapy 8:463-483.
42. Quaglia MG, Desideri N, Bossù E, Melchiorre P & Conti C (1991) Enantiomeric separation by HPLC/DAD of substituted flavanoids. Journal of Pharmaceutical and Biomedical Analysis 9:811-815.
43. Quaglia MG, Desideri N, Bossù E, Sestili I & Conti C (1992) 4′,6-Dichloroflavan (BW863C): enantiomeric separation by HPLC/DAD and antirhinovirus activity. Chirality 4:65-67.
44. Quaglia MG, Desideri N, Bossù E, Sestili I, Tomao P, Conti C & Orsi N (1993) Chiral discrimination and antipicornavirus activity of 6-oxazolinylisoflavan. Chirality 5:356-358.
45. Raghavan K, Buolamwini JK, Fesen M, Pommier Y, Kohn KW & Winstein JN (1995) Three-dimensional quantitative structure-activity relationship (QSAR) of HIV integrase inhibitors: a comparative molecular field analysis (CoMFA) study. Journal of Medicinal Chemistry 38:890-897.
46. Robinson WE, Cordeiro M, Abdel-Malek S, Jia Q, Chow SA, Reinecke MG & Mitchell WM (1996) Dicaffeoylquinic acid inhibitors of human immunodeficiency virus integrase: inhibition of the core catalytic domain of human immunodeficiency virus integrase. Molecular Pharmacology 50:846-855.
47. Schmidt OT & Schach A (1950) Synthese der 3-Galloyl-glucose, 6-Galloyl-glucose und 3,6-Digalloyl-glucose. VIII. Mitteilung über natürliche Gerbstoffe. Liebigs Annalen der Chemie 571:29-41.
48. Smith MA, Neumann RM & Webb RA (1968) A modification of Algar-Flynn-Oymada preparation of flavonols. Journal of Heterocyclic Chemistry 5:425-426.
49. Superti F, Seganti L, Orsi N, Divizia M, Gabrieli R, Panà A & Stein ML (1989) Effect of isoflavans and isoflavenes on the infection of Frp/3 cells by hepatitis A virus. Antiviral Research 11:247-254.
50. Tramontano E & Cheng YC (1992) HIV-1 reverse transcriptase inhibition by a dipyridodiazepinone derivative: BI-RG-587. Biochemical Pharmacology 43:1371-1376.